Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Devi

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Investigative Ophthalmology & Visual Science|December 7, 2007
Glaucoma-associated CYP1B1 mutations share similar haplotype backgrounds in POAG and PACG phenotypesSubhabrata Chakrabarti, Koilkonda R Devi, Sreelatha Komatireddy, et al.
NPJ Breast Cancer|July 29, 2024
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancerGayathri R Devi, Pritha Pai, Seayoung Lee, et al.
Molecular Cancer Therapeutics|January 19, 2008
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionKatherine M Aird, Xiuyun Ding, Aris Baras, et al.
International Journal of Nanomedicine|September 13, 2017
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostarsBridget M Crawford, Ronnie L Shammas, Andrew M Fales, et al.
Journal of Clinical and Translational Science|May 5, 2021
An innovative educational program for addressing health disparities in translational cancer researchCarla E Oldham, M J Gathings, Gayathri R Devi, et al.
Preventive Medicine Reports|December 20, 2023
Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and managementGayathri R Devi, Laura J Fish, Alexandra Bennion, et al.
Cancer Letters|May 22, 2013
Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitizationKevin P Williams, Jennifer L Allensworth, Shalonda M Ingram, et al.
Molecular Cancer Therapeutics|December 16, 2020
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent ApoptosisXuemei Xie, Jangsoon Lee, Huey Liu, et al.
Evolution, Medicine, and Public Health|March 19, 2021
<i>Hymenolepis diminuta</i>-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progressionScott Sauer, Dylan Beinart, Sade M B Finn, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 18, 2002
Carbamazepine-induced eosinophilic enteritisV K Shakeer, Sobhana R Devi, Antony Paul Chettupuzha, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Investigative Ophthalmology & Visual Science|December 7, 2007
Glaucoma-associated CYP1B1 mutations share similar haplotype backgrounds in POAG and PACG phenotypesSubhabrata Chakrabarti, Koilkonda R Devi, Sreelatha Komatireddy, et al.
NPJ Breast Cancer|July 29, 2024
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancerGayathri R Devi, Pritha Pai, Seayoung Lee, et al.
Molecular Cancer Therapeutics|January 19, 2008
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionKatherine M Aird, Xiuyun Ding, Aris Baras, et al.
International Journal of Nanomedicine|September 13, 2017
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostarsBridget M Crawford, Ronnie L Shammas, Andrew M Fales, et al.
Journal of Clinical and Translational Science|May 5, 2021
An innovative educational program for addressing health disparities in translational cancer researchCarla E Oldham, M J Gathings, Gayathri R Devi, et al.
Preventive Medicine Reports|December 20, 2023
Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and managementGayathri R Devi, Laura J Fish, Alexandra Bennion, et al.
Cancer Letters|May 22, 2013
Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitizationKevin P Williams, Jennifer L Allensworth, Shalonda M Ingram, et al.
Molecular Cancer Therapeutics|December 16, 2020
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent ApoptosisXuemei Xie, Jangsoon Lee, Huey Liu, et al.
Evolution, Medicine, and Public Health|March 19, 2021
<i>Hymenolepis diminuta</i>-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progressionScott Sauer, Dylan Beinart, Sade M B Finn, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|July 18, 2002
Carbamazepine-induced eosinophilic enteritisV K Shakeer, Sobhana R Devi, Antony Paul Chettupuzha, et al.
Pageof 21